This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Iovance Biotherapeutics, Inc., Lovance Biotherapeutics, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Maritza Lienlaf Moreno: Innovator in Immunotherapy
Introduction
Maritza Lienlaf Moreno is a prominent inventor based in Tampa, Florida, known for her significant contributions to the field of immunotherapy. With a total of three patents to her name, she has made remarkable strides in the production of tumor-infiltrating lymphocytes (TILs), which are crucial for cancer treatment.
Latest Patents
Her latest patents focus on processes for the production of tumor-infiltrating lymphocytes and their uses in immunotherapy. The inventions provide improved and shortened methods for expanding TILs and producing therapeutic populations of TILs. These novel methods allow for the expansion of TIL populations in a closed system, leading to improved efficacy, enhanced phenotype, and increased metabolic health of the TILs in a shorter time frame. Additionally, these methods reduce microbial contamination and decrease costs, making TILs more accessible for therapeutic treatment regimens.
Career Highlights
Throughout her career, Maritza has worked with notable companies such as Iovance Biotherapeutics, Inc. and Lovance Biotherapeutics, Inc. Her work in these organizations has furthered the development of innovative therapies that harness the power of the immune system to combat cancer.
Collaborations
Maritza has collaborated with various professionals in her field, including her coworker Seth Wardell, to advance research and development in immunotherapy.
Conclusion
Maritza Lienlaf Moreno's contributions to immunotherapy through her innovative patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in cancer treatment.